Insider · CIK 0001882756
Barry Canton
owner
Files at DNA (Ginkgo Bioworks Holdings, Inc.). First filing Oct 13, 2023, latest Apr 13, 2026.
In brief
Barry Canton files SEC Form 4 as 10% owner at DNA (Ginkgo Bioworks Holdings, Inc.). Since Oct 13, 2023, Barry Canton has reported 0 open-market buys worth $0 and 13 open-market sells worth $2.2M, the latest filed on Apr 13, 2026.
A track record needs three past buys with six months of prices behind them; Barry Canton has 0, so none is measured yet.
The newest scored trade: sold $802k of DNA on Apr 10, 2026, filed Apr 13, 2026, scored 39 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $978k.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 13
$0 bought, $2.2M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DNA: Ginkgo Bioworks Holdings, Inc.
DNAOct 12, 2026 · close 11.79
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Ginkgo Bioworks Holdings, Inc. | $802k 124,727 shares | -22% | +18% from low-60% from high | |
| 24Weak | Ginkgo Bioworks Holdings, Inc. | $175k 26,271 shares | -7% | +26% from low-57% from high | |
| 18Weak | Ginkgo Bioworks Holdings, Inc. | $133k 75,300 shares | -1% | +49% from low-33% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $112k 75,300 shares | -1% | +26% from low-43% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $99k 75,300 shares | -1% | +14% from low-49% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $106k 75,300 shares | -1% | +22% from low-45% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $106k 75,300 shares | -1% | +21% from low-46% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $113k 75,300 shares | -1% | +37% from low-42% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $105k 75,300 shares | -1% | +31% from low-48% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $108k 75,300 shares | -1% | +19% from low-52% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $111k 75,300 shares | -1% | +26% from low-49% from high | |
| 17Weak | Ginkgo Bioworks Holdings, Inc. | $124k 75,300 shares | -1% | +45% from low-42% from high | |
| 18Weak | Ginkgo Bioworks Holdings, Inc. | $128k 75,300 shares | -1% | +54% from low-41% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Apr 9, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | 13,116 0.03% of outstanding | $84k | Apr 9, 2026 | $91k |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | 13,155 0.03% of outstanding | $91k | Apr 8, 2026 | none |
| Dec 21, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $66k | Dec 21, 2023 | $1.5M |
| Dec 14, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $56k | Dec 14, 2023 | $1.5M |
| Dec 7, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $49k | Dec 7, 2023 | $1.6M |
| Nov 30, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $53k | Nov 30, 2023 | $1.7M |
| Nov 24, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $52k | Nov 24, 2023 | $1.7M |
| Nov 16, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $59k | Nov 16, 2023 | $1.8M |
| Nov 9, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $52k | Nov 9, 2023 | $1.8M |
| Nov 2, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $53k | Nov 2, 2023 | $1.8M |
| Oct 26, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $55k | Oct 26, 2023 | $1.9M |
| Oct 19, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $62k | Oct 19, 2023 | $2.0M |
| Oct 12, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | 37,650 0.00% of outstanding | $66k | Oct 12, 2023 | $2.0M |
Transactions
Every row this insider has filed, 41 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +35,736 | - | - | 35,736 | Jul 30, 2026 |
| Jul 28, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Restricted Stock Unitsderivative | +117,135 | - | - | 117,135 | Jul 30, 2026 |
| Jul 28, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Spouse | +39,038 | - | - | 39,038 | Jul 30, 2026 |
| Jul 28, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Restricted Stock Unitsderivativeindirect: By Spouse | +127,423 | - | - | 127,423 | Jul 30, 2026 |
| Apr 9, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stockindirect: By Spouse | +251,786 | - | - | 561,149 | Apr 13, 2026 |
| Apr 10, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse | -124,727 | $6.43 | $802k | 436,422 | Apr 13, 2026 |
| Apr 9, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Performance-Based Restricted Stock Unitderivativeindirect: By Spouse | -251,786 | - | - | 0 | Apr 13, 2026 |
| Apr 7, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +27,738 | - | - | 337,101 | Apr 10, 2026 |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Class A Common Stock | +27,738 | - | - | 364,839 | Apr 10, 2026 |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -13,155 | $6.93 | $91k | 351,684 | Apr 10, 2026 |
| Apr 9, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock | -13,116 | $6.40 | $84k | 338,568 | Apr 10, 2026 |
| Apr 7, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Performance-Based Restricted Stock Unitderivative | -27,738 | - | - | 27,738 | Apr 10, 2026 |
| Apr 8, 2026 | DNA Ginkgo Bioworks Holdings, Inc. | MOption exercise Performance-Based Restricted Stock Unitderivative | -27,738 | - | - | 0 | Apr 10, 2026 |
| Apr 25, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Stock Optionderivative | +5,000,000 | $0.00 | $0 | 5,000,000 | Apr 29, 2024 |
| Apr 25, 2024 | DNA Ginkgo Bioworks Holdings, Inc. | AGrant or award Stock Optionderivativeindirect: By Spouse | +5,000,000 | $0.00 | $0 | 5,000,000 | Apr 29, 2024 |
| Dec 20, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.80 | $68k | 12,374,554 | Dec 22, 2023 |
| Dec 21, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.74 | $65k | 12,374,544 | Dec 22, 2023 |
| Dec 13, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -36,829 | $1.34 | $49k | 12,413,025 | Dec 15, 2023 |
| Dec 14, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -821 | $1.48 | $1,215 | 12,412,204 | Dec 15, 2023 |
| Dec 14, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.63 | $61k | 12,412,194 | Dec 15, 2023 |
| Dec 8, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | CConversion Class A Common Stock | +200,000 | - | - | 12,649,844 | Dec 12, 2023 |
| Dec 12, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | GGift Class A Common Stock | -200,000 | $0.00 | $0 | 12,449,844 | Dec 12, 2023 |
| Dec 8, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | CConversion Class B Common Stockderivativeindirect: By Bartholomew Canton Living Trust | -200,000 | - | - | 69,989,783 | Dec 12, 2023 |
| Dec 6, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.32 | $50k | 12,449,854 | Dec 8, 2023 |
| Dec 7, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.32 | $50k | 12,449,844 | Dec 8, 2023 |
| Nov 29, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.45 | $55k | 12,487,504 | Dec 1, 2023 |
| Nov 30, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.35 | $51k | 12,487,494 | Dec 1, 2023 |
| Nov 22, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.40 | $53k | 12,525,154 | Nov 27, 2023 |
| Nov 24, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.42 | $53k | 12,525,144 | Nov 27, 2023 |
| Nov 15, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.54 | $58k | 12,562,804 | Nov 17, 2023 |
| Nov 16, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.45 | $55k | 12,562,794 | Nov 17, 2023 |
| Nov 8, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.50 | $57k | 12,600,454 | Nov 13, 2023 |
| Nov 9, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.29 | $49k | 12,600,444 | Nov 13, 2023 |
| Nov 1, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.34 | $51k | 12,638,104 | Nov 3, 2023 |
| Nov 2, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.52 | $57k | 12,638,094 | Nov 3, 2023 |
| Oct 25, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.48 | $56k | 12,675,754 | Oct 27, 2023 |
| Oct 26, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.46 | $55k | 12,675,744 | Oct 27, 2023 |
| Oct 18, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.69 | $64k | 12,713,404 | Oct 20, 2023 |
| Oct 19, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.61 | $61k | 12,713,394 | Oct 20, 2023 |
| Oct 11, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stockindirect: By Spouse10b5-1 | -37,650 | $1.76 | $66k | 12,751,054 | Oct 13, 2023 |
| Oct 12, 2023 | DNA Ginkgo Bioworks Holdings, Inc. | SOpen-market sale Class A Common Stock10b5-1 | -37,650 | $1.66 | $62k | 12,751,044 | Oct 13, 2023 |
Questions about Barry Canton
Answered from the filings on this page, as of the latest one.
Is Barry Canton buying or selling?
In the last 12 months Barry Canton reported 0 open-market buys worth $0 and 2 open-market sells worth $978k on SEC Form 4; the latest was sold $802k of DNA on Apr 10, 2026. Grants, option exercises and tax withholding are not counted.
How did Barry Canton's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Barry Canton has 0.
Where does Barry Canton file Form 4?
Barry Canton has filed Form 4 at DNA (Ginkgo Bioworks Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.